Company / Cash & Equivalents
Aveanna Healthcare Holdings, Inc. Cash & Equivalents History
FY2020-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$193.3M
FY2026
5-year range
$19.2M / $193.3M
FY2022-FY2026
Trend
+129.3%
vs FY2025
Sector context
#84 of 148
Health Care
What the data says
At $193M, Aveanna Healthcare Holdings, Inc.'s cash & equivalents ranks #84 of 148 in the Health Care sector. Cash & Equivalents has increased for 3 consecutive years, from $19M in FY2022 to $193M in FY2026.
Based on SEC 10-K filings.
$193M in FY2026 with a 5-year CAGR of +44.7%.
Improved from $44M to $193M over the past 3 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +63.8%
- 5-Year CAGR
- +44.7%
- 10-Year CAGR
- -
Sector benchmark
#84 of 148 in Health CareTop 57% of 148This company $193.3M Sector average $1.2B
▼
-83.6% below sector average
Key checks
Key Insights
- Aveanna Healthcare Holdings, Inc.'s cash & equivalents has grown for 3 consecutive years.
- 5-year CAGR of +44.7%, indicating consistent growth.
- In FY2026, cash & equivalents increased 129.3% year-over-year.
- Ranks #84 out of 148 companies in the Health Care sector.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $193.3M | +129.3% |
| FY2024 | $84.3M | +91.8% |
| FY2023 | $43.9M | +128.7% |
| FY2022 | $19.2M | -37.0% |
| FY2021 | $30.5M | -77.8% |
| FY2020 | $137.3M | - |
| FY2019 | - | - |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026